Walgreen
This article was originally published in The Rose Sheet
Executive Summary
Store openings contributed to a 14% rise in sales to $8.2 bil. for the fourth quarter (ended Aug. 31), while net earnings were up 11.9% to $277.1 mil., according to Walgreen. The firm opened 209 stores in the fourth quarter alone to total 4,227 locations. Store expansion in 2004 will be targeted to California, the Carolinas, Florida, Texas and Washington, and the retailer notes it is on track to reach 7,000 stores by 2010. Comparable store sales in Q4 were up 9.9%. Full year revenue was up 13.3% to $32.5 bil., with comparable store sales up 8.6%. Net earnings rose 15.4% to $1.18 bil. Walgreen notes it is budgeting more than $1 bil. in capital investments for the new fiscal year...
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.